Human API's $20M+ Series C, Curve Health's $6M seed round and more digital health fundings

Also: Digital therapeutics company Palo Alto Health Sciences reports $9.1 million; Adherium gains new support from investment firm Viburnum.
By Dave Muoio
12:29 pm
Share
Also: Digital therapeutics company Palo Alto Health Sciences reports $9.1 million; Adherium gains new support from investment firm Viburnum.

Human API, maker of a consumer-facing health data sharing platform, announced last week the close of "over $20 million" in Series C funding. The raise saw backers Samsung Ventures, CNO Financial Group, Allianz Life Ventures and Moneta VC joining returning investors BlueRun Ventures, SCOR Life and Health Ventures, and Guardian Life Insurance Company.

The company's tools connect to a range of data sources – including EHRs, fitness apps and wearables – to aggregate individuals' health information, which they can then share with employers, financial services or other digital health startups. The company said that these funds will help continue to grow its business among insurance, pharma, and digital health clients, and help the platform enable new capabilities. Some of these listed by the startup include automated patient monitoring, population health management, streamlined clinical trial recruitment and chronic disease management.

"With this new capital we’re evolving Human API into a digital transformation platform unifying more data from more sources,” Andrei Pop, founder and CEO of Human API, said in a statement. “We’re speeding up growth in the insurance, clinical trials, and health plans markets, as well as new use cases like COVID-19 screening.” 


Tech-enabled senior care startup Curve Health has brought in $6 million in seed funding. The round was led by Lightspeed Venture Partners and coincides with the announcement of a new CEO, Rob McNaughton, formerly of NurseGrid and Cambia Health Solutions.

The company's platform is a blend of telehealth, smart billing, predictive analytics and a health information exchange, an approach that the company says can deliver higher quality care and better returns on investment. As it works towards its "aggressive market expansion plan that includes working with skilled nursing facilities, hospitals, ambulance companies and physician groups," Curve has partnered with design firm IDEO to flesh out its platform's user experience.

"The combination of insights from the nursing home ecosystem, along with working with Rob, ... who has extensive experience partnering with hospitals and healthcare systems, will ensure that we scale Curve's connected senior care platform as quickly as possible to create a transformative experience for people in their moment of need and foster systemic change in the American healthcare system," said Dr. Tim Pick, Curve's founding CEO, who will be moving into the roles of president and executive chair, said in a statement.


Palo Alto Health Sciences, the maker of an FDA-cleared digital therapeutic, filed a roughly $9.1 million equity raise with the SEC last week. The submission did not indicate any new investors.

The company's therapeutic, called Freespira, is intended to reduce or eliminate panic attack symptoms after 28 days of use. The product was cleared by the FDA back in 2013, although the company has been quiet on the fundraising front since 2016.


Adherium, the maker of Bluetooth-connected sensors for use with prescription inhalers, raised $3 million from Viburnum, per The Market Herald. This comes after the digital inhaler company restructured its business and executive team last year.


CLIMBR, maker of a connected vertical-climbing machine, announced the close of its first funding round. The undisclosed raise was headed by KBW-Ventures, 22 Days Nutrition CEO and founder Marco Borges, and other unnamed backers.

The company's patent-pending exercise machine will include a touch display, an integrated audio system, on-demand live classes and a data-tracking companion app. With this raise, the company will work to launch its products for at-home and commercial customers.

"Unlike bikes, treadmills, and rowers, CLMBR has less impact on the joints, while providing the most efficient calorie burn per minute of any machine in the marketplace," Avrum Elmakis, founder and CEO of the startup, said in a statement. "CLMBR disrupts how people work out and offers something new in a segment that has not seen a lot of meaningful innovation. I'm excited to share the machine with consumers as we become the leader in the connected fitness market."

MobiHealthNews:

The latest news in digital health delivered daily to your inbox.

Thank you for subscribing!
Error! Something went wrong!